Company Monitoring Page for ViiV-Healthcare

latest headlines for company on cafepharma

ViiV Healthcare’s HIV-1 drug fostemsavir succeeds in phase 3 trial
Pharmaceutical Business Review
Thu, 11/1/18 - 10:47 am
Tags:
ViiV Healthcare, HIV, clinical trials, fostemsavir
ViiV Healthcare reports positive results for late-stage HIV trials
Marketwatch
Thu, 06/14/18 - 09:19 am
Tags:
ViiV Healthcare, GSK, Pfizer, Shionogi, HIV, clinical trials, Dolutegravir, lamivudine
ViiV Receives EU Authorization for Juluca, the First 2-Drug, Once-Daily Pill for HIV
CP Wire
Mon, 05/21/18 - 09:08 am
Tags:
ViiV Healthcare, Juluca, Europe, HIV
Mon, 05/21/18 - 08:30 am
Tags:
ViiV Healthcare, HIV, Juluca
ViiV Healthcare Launches Phase III Programme Evaluating a Two-drug Regimen Combining Dolutegravir and Lamivudine for HIV-1 Treatment
Yahoo
Tue, 08/16/16 - 11:14 am
Tags:
ViiV Healthcare, HIV, Dolutegravir, HIV-1, lamivudine
ViiV Healthcare Announces FDA Approval to Lower the Weight Limit for dolutegravir in Children and Adolescents Living With HIV
Yahoo
Fri, 06/10/16 - 10:06 am
Tags:
ViiV Healthcare, HIV, FDA, pediatric, Dolutegravir
Viiv Healthcare expands access to HIV drug through patent pooling
BioPharma Dive
Wed, 04/27/16 - 02:09 pm
Tags:
ViiV Healthcare, HIV, patent pooling, Tivicay
Why ViiV Healthcare leads the pharma industry in corporate reputation
BioPharma Dive
Wed, 03/23/16 - 04:23 pm
Tags:
ViiV Healthcare, Pfizer, GSK, Shionogi, AbbVie, Lundbeck, Janssen, Novo Nordisk
Bristol-Myers Squibb Completes Previously Announced Sale of its HIV R&D Portfolio to ViiV Healthcare
Yahoo
Mon, 02/22/16 - 09:55 pm
Tags:
Bristol-Myers Squibb, HIV, ViiV Healthcare
GlaxoSmithKline On Path To Recovery
Bidness, ETC
Sun, 12/20/15 - 04:35 pm
Tags:
GSK, ViiV Healthcare, Bristol-Myers Squibb
Glaxo to Pay Bristol-Myers Up to $1.46 Billion for HIV Drugs
Bloomberg
Fri, 12/18/15 - 08:45 am
Tags:
GSK, Bristol-Myers Squibb, HIV, ViiV Healthcare
Johnson & Johnson HIV combination succeeds in mid-stage study
Yahoo/Reuters
Tue, 11/3/15 - 09:20 am
Tags:
JNJ, HIV, cabotegravir, rilpivirine, ViiV Healthcare
GSK chief: We don't need a breakup or a Pfizer deal. Just look at ViiV's sales surge
Fierce Pharma
Wed, 10/28/15 - 03:14 pm
Tags:
GSK, Pfizer, M&A, ViiV Healthcare, Andrew Witty
Here’s how GlaxoSmithKline Hopes To Trump Gilead Sciences In HIV Market
Bidness, ETC
Fri, 09/25/15 - 10:15 am
Tags:
Gilead Sciences, GSK, HIV, ViiV Healthcare
ViiV Healthcare - The Hidden Gem Of GlaxoSmithKline's Balance Sheet
Seeking Alpha
Wed, 08/19/15 - 09:17 pm
Tags:
GSK, ViiV Healthcare, Gilead, Pfizer, Bristol-Myers Squibb, HIV
Success at Glaxo's HIV Unit May Mean Having to Call It Quits
Yahoo/Bloomberg
Thu, 07/9/15 - 10:23 am
Tags:
GSK, HIV, ViiV Healthcare
GlaxoSmithKline weighs an IPO for the HIV-focused ViiV as it sharpens the budget axe
Fierce Biotech
Wed, 10/22/14 - 08:32 am
Tags:
GSK, ViiV Healthcare, IPOs, HIV, Pfizer
ViiV’s Triumeq to end Gilead’s monopoly in HIV
Pharmaphorum
Wed, 09/10/14 - 11:33 am
Tags:
ViiV Healthcare, Gilead Sciences, HIV, Triumeq
Glaxo Seeks EU Approval for HIV Drug
Yahoo/Zacks
Tue, 10/29/13 - 10:44 am
Tags:
GSK, Europe, HIV, Tivicay, ViiV Healthcare, abacavir, lamivudine
ViiV Healthcare files new drug application for three-drug HIV pill with US FDA
Pharmaceutical-Technology
Wed, 10/23/13 - 09:57 am
Tags:
HIV, FDA, ViiV Healthcare, Dolutegravir, abacavir, lamivudine

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.